2007
DOI: 10.1016/j.clinthera.2007.09.022
|View full text |Cite
|
Sign up to set email alerts
|

A population-based analysis of statin utilization in British Columbia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
9
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 43 publications
1
9
0
Order By: Relevance
“…[11] Accordingly, the initiation of statins for primary prevention in patients with a baseline LDL-C level below 130 mg/dl (3.37 mmol/l) could, as shown in this study, be deemed unjustified. The results identified were consistent with the findings by Raymond and colleagues [31] which showed that approximately 40% of statin usage was not necessary.…”
Section: Statins Utilisation Pattern In Thailandsupporting
confidence: 91%
“…[11] Accordingly, the initiation of statins for primary prevention in patients with a baseline LDL-C level below 130 mg/dl (3.37 mmol/l) could, as shown in this study, be deemed unjustified. The results identified were consistent with the findings by Raymond and colleagues [31] which showed that approximately 40% of statin usage was not necessary.…”
Section: Statins Utilisation Pattern In Thailandsupporting
confidence: 91%
“…While a range of studies have explored the increasing statin utilization according to gender and age [2,4,[22][23][24][25], others have demonstrated that guideline implementation tend to increase in drug utilization [4,5,26]. However, it has been questioned whether statins are prescribed to those who benefit most i.e.…”
Section: Introductionmentioning
confidence: 99%
“…While "new initiators" represent a population that may be of particular interest, they are only a small proportion of all patients on a therapy at any given point in time. 10 As a consequence, quality improvement interventions aimed at improving adherence, such as the Medicare star ratings, which are a critical part of Part D reimbursement, usually consider all patients on therapy and not only those who have newly initiated therapy. 11 Further, these programs generally take the perspective of a defined period of calendar time, rather than time relative to when a patient starts treatment.…”
mentioning
confidence: 99%